Previous 10 | Next 10 |
The following slide deck was published by Vericel Corporation in conjunction with their 2022 Q2 earnings call. For further details see: Vericel Corporation 2022 Q2 - Results - Earnings Call Presentation
Vericel press release ( NASDAQ: VCEL ): Q2 GAAP EPS of -$0.19 misses by $0.07 . Revenue of $37.05M (-6.3% Y/Y) misses by $1.3M . FY2022 Outlook : Total revenue guidance maintained at $178M to $189M vs. consensus of $182.19M; MACI revenue guidance maint...
Second Quarter Total Net Revenue of $37.0 Million MACI Net Revenue of $28.6 Million Conference Call Today at 8:30am Eastern Time CAMBRIDGE, Mass., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports med...
YAVNE, Israel, Aug. 03, 2022 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD) (“MediWound”), a fully-integrated biopharmaceutical company focused on next-generation biotherapeutic solutions for tissue repair and regeneration, today announced that the U.S. Food and Drug Admini...
Vericel ( NASDAQ: VCEL ) is scheduled to announce Q2 earnings results on Wednesday, August 3rd, before market open. The consensus EPS Estimate is -$0.12 (-50.0% Y/Y) and the consensus Revenue Estimate is $38.35M (-3.0% Y/Y). Over the last 2 years, VCEL has beaten EPS...
Data published in the Journal of Burn Care & Research show 83% of patients with posterior burns (mean total body surface area of 56%) had successful engraftment of Epicel after one or two applications 90% survival rate following Epicel and/or Epicel plus split thicknes...
CAMBRIDGE, Mass., July 20, 2022 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that it will report its second-quarter 2022 financial results on Wednesday, August 3, 2022. Vericel...
Image source: The Motley Fool. Vericel (NASDAQ: VCEL) Q1 2022 Earnings Call May 04, 2022 , 8:30 a.m. ET Operator Continue reading For further details see: Vericel (VCEL) Q1 2022 Earnings Call Transcript
Vericel Corp (VCEL) Q1 2022 Earnings Conference Call May 04, 2022, 08:30 ET Company Participants Eric Burns - Executive Director, Financial Planning and Analysis & IR Dominick Colangelo - CEO, President & Director Joseph Mara - CFO & Treasurer Conference Call Participants Ryan Zim...
Vericel press release (NASDAQ:VCEL): Q1 GAAP EPS of -$0.15 misses by $0.03. Revenue of $36.07M (+4.3% Y/Y) beats by $1.76M. The company reaffirmed financial guidance for FY2022: Total net revenue in the range of $178M to $189M vs. consensus of $183.62M; MACI revenue expected to be in the...
News, Short Squeeze, Breakout and More Instantly...
CAMBRIDGE, Mass., July 22, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the appointment of Karen Mahoney as Chief Human Resources Officer following the retirement of Heidi Hassen, w...
CAMBRIDGE, Mass., July 18, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that it will report its second-quarter 2024 financial results on Thursday, August 1, 2024. Vericel’s m...
2024-07-08 00:00:04 ET Ryan Zimmerman from BTIG issued a price target of $56.00 for VCEL on 2024-07-05 10:09:00. The adjusted price target was set to $56.00. At the time of the announcement, VCEL was trading at $46.68. The overall price target consensus is at $48.00 with...